Free Delivery on all orders over £39 *Exclusions Apply*

Product image

Alamycin LA 300mg/ml injection 100ml

£26.52

Alamycin LA 300mg/ml  is indicated for the treatment and control of pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint-ill, navel-ill, summer mastitis in cows, ovine keratoconjunctivitis (pink-eye) and enzootic abortion in sheep.

Legal Category : POM-V

This product requires a valid veterinary prescription for purchase

Read More

Upload Prescriptions

  • Prescription *

    Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe png gif pdf

Product total

Options total

Grand total

View POM

Delivery

All orders over £39 receive free delivery * *terms and conditions apply

Returns

Returns It should be noted that, unfortunately, we cannot accept returns of any labelled products, including prescription medicines and flea and worming products. If the customer has requested a cancellation but the order has already been dispatched then we will not be able to cancel and refund the order. This also applies if the customer has ordered the incorrect dosage. Returns of any labelled products are only acceptable if it is due to an error in processing, or for an official recall. We are also unable to accept the returns of Caninsulin syringes, even if the packaging is unopened.

View More

Description

Alamycin LA 300mg/ml injection is used for the treatment of conditions caused by or associated with organisms sensitive to oxytetracycline including:

Bordetella bronchiseptica

Actinomyces pyogenes

Erysipelothrix rhusiopathiae

Pasteurella spp

Staphylococcus spp

Streptococcus spp

Certain mycoplasma, rickettsiae, protozoa and chlamydia are also sensitive to oxytetracycline.

Alamycin LA is indicated for the treatment and control of pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint-ill, navel-ill, summer mastitis in cows, ovine keratoconjunctivitis (pink-eye) and enzootic abortion in sheep.

Use of the product should be based on susceptibility testing of bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information on susceptibility of the target bacteria.